» Articles » PMID: 2189894

Double Minutes Arise from Circular Extrachromosomal DNA Intermediates Which Integrate into Chromosomal Sites in Human HL-60 Leukemia Cells

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1990 Jun 1
PMID 2189894
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Amplification of oncogenes has been found to be an important prognostic factor in behavior of patients' malignancies. In this study we have used new gel electrophoresis techniques to follow the location of amplified c-myc oncogene sequences in HL-60 promyelocytic leukemia cells. In passages 46-62 of the cells, the cells contain amplified c-myc sequences on submicroscopic circular extrachromosomal DNA (episomes). With increased passages in culture (passages 63-72) the cells lose the episome c-myc sequences with a shift of those sequences to double minutes. With additional passage in culture, the c-myc shifts from the double minutes to a chromosomal site der(5)t(5;17)(q11.2;q?11.2). Concomitant with the shift of the c-myc sequences into the chromosomal compartment is a phenotypic change of a shortened cell-doubling time. These studies provide the first molecular evidence of a progression from a submicroscopic location for amplified oncogene sequences to a chromosomal location for the amplified sequences. This molecularly documented model can now be used to test various strategies to prevent incorporation of extrachromosomally located oncogene sequences into chromosomal sites. Prevention of integration of the oncogene sequences into chromosomal sites could modulate progression of patients' tumors.

Citing Articles

Unveiling the mysteries of extrachromosomal circular DNA: from generation to clinical relevance in human cancers and health.

Wang Z, Yu J, Zhu W, Hong X, Xu Z, Mao S Mol Cancer. 2024; 23(1):276.

PMID: 39707444 PMC: 11660679. DOI: 10.1186/s12943-024-02187-5.


Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome change.

Dehkordi S, Wong I, Ni J, Luebeck J, Zhu K, Prasad G bioRxiv. 2024; .

PMID: 38168210 PMC: 10760206. DOI: 10.1101/2023.12.12.571349.


Extrachromosomal DNA (ecDNA) in cancer: mechanisms, functions, and clinical implications.

Dong Y, He Q, Chen X, Yang F, He L, Zheng Y Front Oncol. 2023; 13:1194405.

PMID: 37448518 PMC: 10338009. DOI: 10.3389/fonc.2023.1194405.


Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications.

Luo J, Li Y, Zhang T, Xv T, Chen C, Li M Front Oncol. 2023; 12:1092705.

PMID: 36793345 PMC: 9923117. DOI: 10.3389/fonc.2022.1092705.


Extrachromosomal circular DNA: biogenesis, structure, functions and diseases.

Yang L, Jia R, Ge T, Ge S, Zhuang A, Chai P Signal Transduct Target Ther. 2022; 7(1):342.

PMID: 36184613 PMC: 9527254. DOI: 10.1038/s41392-022-01176-8.


References
1.
Hozier J, Lindquist L . Banded karyotypes from bone marrow: a clinical useful approach. Hum Genet. 1980; 53(2):205-9. DOI: 10.1007/BF00273497. View

2.
Spriggs A, Boddington M, Clarke C . Chromosomes of human cancer cells. Br Med J. 1962; 2(5317):1431-5. PMC: 1926782. DOI: 10.1136/bmj.2.5317.1431. View

3.
Cowell J . Chromosome abnormalities associated with salivary gland epithelial cell lines transformed in vitro and in vivo with evidence of a role for genetic imbalance in transformation. Cancer Res. 1981; 41(4):1508-17. View

4.
Schimke R, BROWN P, Kaufman R, McGrogan M, Slate D . Chromosomal and extrachromosomal localization of amplified dihydrofolate reductase genes in cultured mammalian cells. Cold Spring Harb Symp Quant Biol. 1981; 45 Pt 2:785-97. DOI: 10.1101/sqb.1981.045.01.097. View

5.
Barker P . Double minutes in human tumor cells. Cancer Genet Cytogenet. 1982; 5(1):81-94. DOI: 10.1016/0165-4608(82)90043-7. View